Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: A randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Rebamipide is a quinolinone-derived gastroprotective agent approved in Korea for the
treatment of gastric ulcers, acute gastritis, and exacerbated chronic gastritis.